Clinical trials
Thalassemia trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 4 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UCSF Benioff Children's Hospital Oakland | 3 |
| Alexandria University | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Baylor College of Medicine | 1 |
| Beni-Suef University | 1 |
| Chiang Mai University | 1 |
| Columbia University | 1 |
| Duke University | 1 |
| Emory University | 1 |
| First Affiliated Hospital of Guangxi Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thalassemia | 31 |
| Anemia, Sickle Cell | 7 |
| beta-Thalassemia | 6 |
| Iron Overload | 5 |
| Anemia, Aplastic | 2 |
| Anemia, Diamond-Blackfan | 2 |
| Hemoglobinopathies | 2 |
| Pain | 2 |
| Anxiety Disorders | 1 |
| Autoimmune Diseases | 1 |
Trials
Showing 26 to 31 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.